BlackRock Fund Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

BlackRock Fund Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$29.5M	Buy	264,098 +56,824	+27%	+$6.84M	0.01%	1971
2016 Q3	$27.5M	Buy	207,274 +9,386	+5%	+$897K	0.01%	1913
2016 Q2	$18.1M	Sell	197,888 -1,359	-0.7%	-$114K	﹤0.01%	2084
2016 Q1	$14.4M	Buy	199,247 +25,766	+15%	+$1.41M	﹤0.01%	2169
2015 Q4	$12M	Sell	173,481 -37,939	-18%	-$3.09M	﹤0.01%	2339
2015 Q3	$19.3M	Buy	211,420 +57,950	+38%	+$6.44M	0.01%	2008
2015 Q2	$18.9M	Buy	153,470 +6,488	+4%	+$736K	﹤0.01%	2148
2015 Q1	$13.4M	Buy	146,982 +7,792	+6%	+$633K	﹤0.01%	2286
2014 Q4	$9.42M	Buy	+139,190	New	+$10.2M	﹤0.01%	2496

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock Fund Advisors's GWPH Position: Q4 2016 in Review

BlackRock Fund Advisors increased its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 27% in Q4 2016, buying an estimated $6.84M and bringing the position to 264,098 shares worth $29.5M. The position accounts for 0.01% of the portfolio, ranked #1971.

BlackRock Fund Advisors first reported a position in GWPH in Q4 2014 and has held it in 9 quarters since. 164 funds tracked by Wall St. Rank hold GWPH as of Q4 2016.

BlackRock Fund Advisors held 264,098 shares of GW Pharmaceuticals Plc American Depositary Shares worth $29.5M as of Q4 2016.
BlackRock Fund Advisors bought 56,824 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2016, an estimated $6.84M.
GW Pharmaceuticals Plc American Depositary Shares made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1971 holding.
BlackRock Fund Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and has held it in 9 quarters since.
164 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.